Laguna Niguel, CA, United States of America

Mohammed I Dibas

This inventor holds 16 USPTO granted patents and 40 published patent applications, plus 6 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Compositions. Top assignee: Allergan, Inc.. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed I Dibas. Retrieved from https://idiyas.com/inventor/mohammed-i-dibas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Mission Viejo, CA (US) (2014 - 2018)
  • Laguna Niguel, CA (US) (2013 - 2022)
  • Corona, CA (US) (2020 - 2022)

Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Presbyopia Treatments
Retinal Diseases
Alpha-2 Adrenergic Agonists
Imidazole Derivatives
Skin Diseases
Intraocular Pressure
Modulators
Ester Pro-drugs
Heterocyclopenta Derivatives
16 patents (USPTO):Explore Patents

Title: Mohammed I Dibas: Pushing Boundaries in Innovation

Introduction: Mohammed I Dibas is a remarkable inventor based in Laguna Niguel, CA (US) who continues to be a driving force in the world of innovation. With a passion for creating cutting-edge solutions that push the boundaries of what is possible, Dibas is known for his dedication to his craft and commitment to excellence.

Latest Patents: Dibas holds an impressive 16 patents, with his latest inventions focusing on revolutionary pharmaceutical compositions. One of his recent patents includes Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases. This invention aims to treat retinal diseases, provide retinal neuroprotection, and enhance vision. Another notable patent is related to Presbyopia treatments, offering methods and compositions for the improvement of vision parameters using ophthalmic pilocarpine formulations.

Career Highlights: Dibas is a valuable asset to Allergan, Inc., where he contributes his expertise in innovation and pharmaceutical research. His innovative approach and keen eye for detail have earned him recognition as a standout inventor in the industry. With a keen focus on developing solutions that make a difference, Dibas has made significant contributions to the field of ophthalmology.

Collaborations: In his professional journey, Dibas has collaborated with talented individuals such as Daniel W Gil and John E Donello. These collaborations have led to the creation of groundbreaking inventions and have further solidified Dibas' reputation as a forward-thinker in the industry.

Conclusion: Mohammed I Dibas' unwavering passion for innovation and his commitment to excellence have set him apart as a leading inventor in the field. His groundbreaking inventions and dedication to pushing boundaries continue to inspire and influence the world of ophthalmology and pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…